Nano2Life: European Researchers Develop Joint Nanobiotechnology Research Projects

Twente/Netherlands, Sep 27th, 2005. The focus of this meeting is set on the initiation of twelve strategic research programmes (SRP). The 12 SRP include 6 technology driven SRP (SRP-T) and 6 application driven (SRP-A):

• Surface functionalisation and nano patterning
• Protein, DNA and cell chips
• Non-carbon nanotubes, nanoscale assemblies and self assemblies
• In-vivo nano-imaging
• In vivo cell and tissue analysis
• Bioanalytics instrumentation
• Cancer related nanodiagnostics
• Nano-bio-info-cogno applied to neurodegenerative medicine
• Cell biology
• Environment monitoring and security
•In vitro toxicology
•Drug delivery including theranostics

The SRP goal is to lay ground and built a platform of multidisciplinary R&D in nanobiotech, involving basic research and industry while supporting the N2L general objectives:

• becoming an EU reference network in nanobiotech
• transforming the SRP into European task forces in their specific areas of expertise.

Founded in 2004, N2L comprises 23 major European organizations and 41 industrial companies within the field of Nanobiotechnology as well as associate members from EU candidate countries, South Korea, Japan, Australia and North America.